GSK Lifts Outlook After Sales Boost
Wall Street Journal
GSK said its fourth-quarter sales topped £8 billion, thanks to its best-selling shingles vaccine, and raised its guidance for 2024.
https://www.wsj.com/articles/gsk-sales-rose-on-shingles-vaccine-growth-rsv-drug-launch-1c28216c